• br Funding br Introduction l Dihydroxyphenylalanine l DOPA i

  2024-04-25

  

  Funding Introduction l-3,4-Dihydroxyphenylalanine (l-DOPA) is the gold-standard treatment for the motor symptoms of Parkinson's disease (PD); however, its chronic use induces severe motor complications that eventually limit its long-term efficacy (Bastide et al., 2015). The most disabling side

• Pompe disease is accompanied by the

  2024-04-25

  

  Pompe disease is accompanied by the deficiency of the lysosomal α-1,4-glucosidase that makes the CCG-1423 unable to hydrolyze glycogen to glucose, thereby resulting in the accumulation of glycogen in lysosomes, especially in skeletal muscles and cardiac tissues. This accumulation results in the str

• Investigating these possibilities will illuminate

  2024-04-25

  

  Investigating these possibilities will illuminate whether SB 203580 possess mechanisms to differentially detect ACLY-generated versus ACSS2-generated acetyl-CoA as well as define the functional relationship between histone acetylation levels and cellular functions and phenotypes. Given that ACLY dom

• br Experimental section br Competing interests br Author

  2024-04-25

  

  Experimental section Competing interests Author's contributions Acknowledgement This research is partially supported by a seed fund for the Center for Drug Discovery and Translational Research (LS) and a research grant by Fujifilm (VPS and LS). The Sponsors played no roles in study desig

• AP activation is known to upregulate downstream target

  2024-04-25

  

  AP-1 activation is known to upregulate downstream target genes including Triciribine D1, c-myc, Bcl-xl, MMP-9, EGFR, and specific miRNAs that are involved in progression and metastasis of tumors. Moreover, matrix metalloproteinase-2 has been shown as a downstream gene of AP-1, triggered by 15-HETE i

• br Current limitations and future directions There are sever

  2024-04-25

  

  Current limitations and future directions There are several limitations associated with PET imaging of aromatase using carbon-11 labeled aromatase inhibitors. Due to the very short half-life of carbon 11 (20min), PET studies with currently available, validated tracers can only be performed in med

• Optical coherence tomography angiography is another

  2024-04-24

  

  Optical coherence tomography angiography is another promising method for the assessment of corneal neovascularization. This relatively new modality is not yet widely used in part because of current limitations in the definition of images produced, lack of functional information, and inability to det

• br Natriuretic peptides and neprilysin

  2024-04-24

  

  Natriuretic peptides and neprilysin Left ventricular systolic function, most commonly due to myocardial damage as a consequence of coronary artery disease, hypertension or both, and leading to sustained, pathological activation of the renin angiotensin notch signaling system (RAAS) and sympatheti

• br Angiotensin receptor neprilysin inhibitors Sacubitril val

  2024-04-24

  

  Angiotensin receptor-neprilysin inhibitors Sacubitril/valsartan is the first-in-class ARNI, comprising of molecular moieties of valsartan (ARB) and a neprilysin inhibitor prodrug, sacubitril (AHU377) [51]. Upon ingestion, sacubitril is rapidly metabolised into an active neprilysin inhibitor, sacu

• Immunohistochemistry in tissue samples showed the

  2024-04-24

  

  Immunohistochemistry in tissue samples showed the expression of several nuclear receptor co-activators, including NCOA1, NCOA2, NCOA3, CREBBP, and EP300, in 85–100% of Cyclic Pifithrin-α hydrobromide tumors even some of which lacked AR expression (Boorjian et al., 2009). Knockdown of each co-activat

• Beclomethasone dipropionate br Perspectives br Acknowledgmen

  2024-04-24

  

  Perspectives Acknowledgments This investigation was supported by a Research Grant 2010/01385-5 from FAPESP (Sao Paulo Research Foundation, Brazil). P.F.S. was recipient of a CNPq (National Council for Scientific and Technological Development, Brazil) productivity grant. R.F.A. was recipient of

• The results of cell culture models were

  2024-04-24

  

  The results of cell culture models were further supported by in vivo studies in mice treated with PXR and/or AhR agonists, PCN and β-NF. In these mice, AhR-regulated cyp1a1, and cyp1a2 were suppressed by PXR activation as determined by real time Q-PCR (Fig. 3). The level of PXR mRNA was not changed

• In conclusion we have shown that mGlu receptors

  2024-04-24

  

  In conclusion, we have shown that mGlu7 receptors negatively regulate α1-adrenergic receptor signalling in heterologous expression systems, Fmoc-Arg(Pbf)-OH tissue and living animals. This interaction might represent a protective mechanism aimed at restraining an excessive activation of noradrenergi

• br A novel therapeutic strategy based on

  2024-04-24

  

  A novel therapeutic strategy based on the APN and obesity paradoxes As shown above, the relationship of the serum APN concentration with health and disease states shows an inverted-U correlation, suggesting that moderate concentrations of serum APN are beneficial (Fig. 3). Given that both hypo- a

• The total IgG concentration decreased from a mean of mg

  2024-04-24

  

  The total IgG concentration decreased from a mean of 997 mg/100 ml before treatment to a mean of 696 after treatment in the MuSK+MG patients, and from a mean of 1736 mg/100 ml to a mean of 802 mg/100 ml in the AChR+MG patients (normal values 723–1685 mg/100 ml). This decrement was also statistically

8039 records 203/536 page Previous Next First page 上5页 201202203204205 下5页 Last page